Streetbeat News

Earnings

MBRX

Moleculin Biotech announced a positive preliminary update on its lead program MB-106 for Acute Myeloid Leukemia treatment, highlighting a 60% CRc rate with its Annamycin and Cytarabine combination (AnnAraC) in 2nd line AML subjects. The update also noted no signs of cardiotoxicity in all 82 subjects across multiple studies and mentioned the potential for accelerated approval as it advances towards a pivotal AML study in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:36 am

VIOT

Viomi Technology Co (NASDAQ:VIOT) reported a quarterly loss of $(0.17) per share with sales amounting to $351.19 million.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:35 am

AAPL

VGT

XLK

Apple Inc (AAPL) is planning to launch its Vision Pro headset in China within the year, as announced by CEO Tim Cook. The headset, priced at $3,500 in the US, marks Apple's entry into the virtual and augmented reality market. Despite a 24% drop in iPhone sales in China and a 13% decrease in revenue to $20.8 billion in the December quarter, Apple remains optimistic about the Chinese market. The stock can be accessed through ETFs like Vanguard Information Tech ETF (VGT) and SPDR Select Sector Fund - Technology (XLK). AAPL shares saw a slight decrease of 0.35% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 11:34 am

TOVX

Theriva Biologics reported a FY EPS of $(1.14), surpassing the $(1.28) estimate, marking a 12.98% improvement from last year's $(1.31) per share loss. As of December 31, 2023, the company has $23.2M in cash, expected to last until Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:32 am

KPRX

Kiora Pharma reported a Q4 net loss of $2.3 million and ended the quarter with a cash balance of $2.5 million.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:07 am

BITF

Bitfarms has reaffirmed its year-end 2024 guidance, aiming to achieve a hash rate of 21 EH/s and an energy efficiency of 21 w/TH. This announcement underscores the company's commitment to enhancing its mining capabilities and operational efficiency.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:05 am

DWAC

FDX

On March 22nd, U.S. stock markets closed mixed with the S&P 500 nearly unchanged, marking its biggest weekly rise of 2024 after the Fed's interest rate cut plans. The Nasdaq increased slightly, driven by AI excitement. Baker Hughes reported a decrease in U.S. oil rigs. FedEx surged 7.4% after beating profit expectations, while Digital World Acquisition fell 13.7% following its merger approval with Trump's tech company. Global markets saw mixed results, with declines in Asia and Europe, while commodities like crude oil and gold traded higher.

Portfolio Pulse from Akanksha Bakshi

March 25, 2024 | 11:03 am

XBIO

Xenetic Biosciences (NASDAQ:XBIO) reported Q4 GAAP EPS of $(0.77), beating the $(0.87) estimate, but missed sales estimates with $671.96K versus the expected $680.00K. This represents a 23% improvement in EPS and a 37.99% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 10:59 am

NSANY

Nissan Motor Co., Ltd (OTC:NSANY) announced plans to introduce 30 new models by fiscal 2026, aiming for a global sales increase of 1 million vehicles with a focus on electrification. Of these, 16 will be electrified models, with a goal to reduce the cost of EVs by 30% by 2030. The company targets an operating profit margin over 6% and total shareholder returns above 30% by 2030. Nissan plans to invest over ¥400 billion in battery capacity, with electrification investment exceeding 70% by fiscal 2026. The new business plan could unlock an additional ¥2.5 trillion in revenues by 2030. NSANY shares closed higher by 2.18% at $8.45.

Portfolio Pulse from Shivani Kumaresan

March 25, 2024 | 10:44 am